• Deracoxib–Doxorubicin Effects on Canine Mammary Epithelial C

  2026-05-20

  This study investigates how deracoxib, a selective COX-2 inhibitor, modulates the cytotoxic and apoptotic effects of doxorubicin on normal canine mammary epithelial cells. The findings reveal that deracoxib reduces doxorubicin-induced apoptosis and nitric oxide production, highlighting a protective effect that has implications for reducing chemotherapeutic toxicity in preclinical veterinary oncology.

• BFH772 (VEGFR2 Inhibitor): Technical Use, Protocols, and QC

  2026-05-19

  BFH772 is a potent and selective VEGFR2 inhibitor designed for research applications requiring precise modulation of VEGFR2-driven angiogenesis, particularly in tumor angiogenesis models. It should not be used in workflows demanding water solubility or broad-spectrum kinase inhibition due to its defined selectivity and solubility properties.

• Rhodamine B in Pesticide Drift & Cell Labeling: Protocols &

  2026-05-19

  Rhodamine B (Basic Violet 10) stands out as a versatile fluorescent probe, excelling in both environmental tracing of pesticide spray drift and advanced cell labeling. Recent comparative studies and high-purity supply from APExBIO enable researchers to achieve reproducible, quantitative results across diverse fluorescence-based workflows.

• Hypoxia-Induced Cognitive Impairment: Choroid Plexus and AMP

  2026-05-18

  This study provides mechanistic insights into how hypoxic exposure at simulated high altitude disrupts cognitive function in mice by impairing the choroid plexus barrier and driving M1 macrophage polarization via aberrant AMPK signaling. The findings highlight the choroid plexus as a central immunomodulatory hub and suggest new avenues for targeting hypoxia-induced CNS dysfunction.

• Ciprofloxacin Hydrochloride: Mechanistic Insights for Antiba

  2026-05-18

  Explore the multifaceted mechanisms and advanced research applications of ciprofloxacin hydrochloride, a leading fluoroquinolone antibiotic. This article reveals single-cell and immunomodulatory insights that shape next-generation antibacterial assay design.

• Neticonazole Hydrochloride: Innovations in Antifungal and Co

  2026-05-17

  Explore the dual roles of Neticonazole Hydrochloride as an imidazole antifungal and its emerging utility in colorectal cancer models. This article uniquely integrates recent nanotherapeutic advances and mechanistic insights, offering researchers a comprehensive, evidence-based perspective.

• Partial BACE1 Inhibition Lowers Amyloid-β Without Synaptic L

  2026-05-16

  Satir et al. (2020) demonstrate that partial inhibition of BACE1 can reduce amyloid-β production by up to 50% without impairing synaptic transmission in cultured neurons. This evidence supports a strategy of moderate BACE1 inhibitor exposure to balance efficacy and safety in Alzheimer's disease research.

• Deracoxib and Piroxicam Cytotoxicity in Canine Osteosarcoma

  2026-05-15

  This study systematically evaluates the cytotoxic effects of two NSAIDs, deracoxib and piroxicam, on canine osteosarcoma cell lines in vitro. The findings reveal deracoxib's greater potency over piroxicam in reducing osteosarcoma cell viability, with limited impact on fibroblasts and no evidence of apoptosis induction, guiding future directions for targeted cancer research.

• CDK9 Inhibitor (A3294): Technical Use and Protocol Guidance

  2026-05-15

  The CDK9 inhibitor (A3294) offers highly selective inhibition of cyclin dependent kinase 9, enabling precise studies of transcription elongation and HIV-1 propagation with minimal cytotoxic risk. It is not appropriate for experiments requiring broad-spectrum CDK inhibition or protocols that necessitate long-term storage of working solutions.

• Recombinant Human Oncostatin M: Optimizing Fibroblast Assays

  2026-05-14

  Leverage Recombinant Human Oncostatin M (E.coli, Tag Free, Lyophilized) for advanced, reproducible cell-based assays. Discover protocol enhancements and troubleshooting strategies that directly translate recent mitochondrial quality insights into fibroblast proliferation workflows.

• Haloprogin: Translational Leverage in Antifungal Research

  2026-05-14

  This article dissects the biological mechanisms, experimental paradigms, and strategic translational opportunities surrounding Haloprogin (1,2,4-trichloro-5-((3-iodoprop-2-yn-1-yl)oxy)benzene). Integrating landmark literature, competitive insights, and practical protocol guidance, it empowers researchers to harness Haloprogin for advanced dermatophyte, Candida, and Gram-positive infection models. With a focus on evidence-driven optimization and clinical relevance, this perspective positions Haloprogin as a next-generation tool for bridging preclinical and translational mycology.

• Annexin-V Detection of Cardiomyocyte Death in Murine I/R Inj

  2026-05-13

  This study demonstrates the use of labeled recombinant annexin-V as a precise in situ marker for early and late cardiomyocyte death in a mouse model of myocardial ischemia/reperfusion (I/R) injury. The findings refine our understanding of the temporal dynamics of cell death after I/R and offer a sensitive platform for evaluating cell death–blocking therapies.

• Astrocytic GAT-3 Controls Synaptic Transmission and Memory i

  2026-05-13

  This study uncovers how astrocytic GAT-3 regulates synaptic transmission and contextual memory formation in the dentate gyrus. By integrating advanced electrophysiology, optogenetics, and behavioral assays, the authors demonstrate a critical astrocyte-mediated mechanism for GABAergic modulation of excitatory circuits with implications for cognitive function and disease.

• P2RX1 Drives Mitochondrial Apoptosis via CaMKII/PI3K-Akt Sup

  2026-05-12

  Li et al. (2025) reveal that P2RX1 overexpression sensitizes Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) cells to mitochondrial apoptosis by disrupting calcium homeostasis and suppressing PI3K/Akt signaling. These mechanistic insights highlight P2RX1 as a potential therapeutic target and inform advanced apoptosis detection assay strategies.

• E-64d: Advanced Strategies for Cysteine Protease Inhibition

  2026-05-12

  Explore how E-64d enables precise cysteine protease inhibition in living cells, with a deep dive into calpain-targeted research and unique protocol insights. Uncover advanced applications, mechanistic clarity, and practical assay guidance for scientists using E-64d.

16025 records 1/1069 page Next 12345 下5页 Last page